PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-3

  1. 4,285 Posts.
    lightbulb Created with Sketch. 6802
    I think Im liking it....

    https://hotcopper.com.au/data/attachments/4724/4724599-f6c0bec2164ebcdb12348cb809c39687.jpg

    Dogs double the mean imclincial improvement:



    Last edited by Mozzarc: 04/10/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.